Hancock Jaffe Laboratories (HJLI) Stock Analysis
DELISTED 2021
What happened to Hancock Jaffe Laboratories (HJLI) stock?
Hancock Jaffe Laboratories (HJLI) no longer trades on public markets. It was delisted in October 2021. The figures below are historical and are not a current quote.
- Status:
- Delisted — no longer trades
- Delisting date:
- October 2021
- Last recorded price (historical):
- $10.38 (last quote on record before the October 2021 delisting; historical, not a current quote)
Market cap $98.3M is the value of all shares combined.
For informational purposes only. Not financial advice. Data sources: Financial Modeling Prep, Yahoo Finance, SEC EDGAR
Hancock Jaffe Laboratories (HJLI). Hancock Jaffe Laboratories, Inc. is a development stage medical device company focused on tissue-based solutions for cardiovascular and peripheral vascular diseases. The company is developing bioprosthetic implantable devices, including a bioprosthetic heart valve and venous valve.
Last analyzed: Mar 18, 2026Hancock Jaffe Laboratories (HJLI) Healthcare & Pipeline Overview
More about this archive record
Can I still buy HJLI shares?
No. HJLI stopped trading on public markets in October 2021, so the shares are not available through a broker. Anything you see quoted for HJLI elsewhere is historical data, not a live market.
Are the figures on this page current?
No. Every number here is the last value recorded before HJLI stopped trading. Nothing on this page updates, and none of it is a current quote.
Why does this page still exist?
Because people still search for what happened to Hancock Jaffe Laboratories. An archived profile that states the delisting plainly is more useful than a dead link — provided it is labelled as history, which is what this page does.
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.